http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-100456-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f40b145cae5a0fb07fa32b8c0102e8c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05135bd460e276b2213cb22a0c13c22f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c178494eb74fce45934eeab42c1df1f9 |
| publicationDate | 2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-100456-U |
| titleOfInvention | METHOD OF PREVENTION OF PREGNANT PREGNANCY IN WOMEN WITH PATIENTAL PATHOLOGY |
| abstract | A method for the prevention of preterm birth in women with a benign pathology of the cervix uterus in the anamnesis includes a statement of pregnancy in women treated for benign diseases of the cervix against the background of a proven inflammatory reaction. For the prevention of preterm labor, drugs are prescribed: endometrine, 1 vaginal tablet twice a day intravaginally from 22 weeks to 34 weeks of pregnancy, neotrizol 1 suppository once a day intravaginally, from 10-12, 20-22, 32-34 weeks of pregnancy, accordingly, probizin-femin 1 capsule twice a day in the periods of 10-12, 20-22, 32-34 weeks of pregnancy, respectively. |
| priorityDate | 2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553937 |
Total number of triples: 14.